Skip to content
Support us
  • Español
  • English
IBioBA
Instituto de Investigación en Biomedicina de Buenos Aires | CONICET – Instituto Partner de la Sociedad Max Planck
IBioBAIBioBA
  • Home
  • Research
    • Research lines
      • Research areas
      • Neuroscience
      • Cellular Plasticity
      • Molecular Targeting
      • Max Planck Guest Laboratory
    • Scientific Cores Facilities
      • Scientific Cores Facilities
      • Microscopy Platform
      • Cytometry and Cell Sorting Platform
      • Bioinformatics Core Facility
  • Institutional
    • About us
    • Authorities and Staff
    • Scientific Advisory Board
    • Board of Trustees
    • Facts & Figures
    • Institutional Relations and Society
  • Communication
    • News
    • Events
    • Press and Multimedia
    • Max Planck Research Magazine
  • Career
  • Contact
 
  • Home
  • Research
    • Research lines
      • Research areas
      • Neuroscience
      • Cellular Plasticity
      • Molecular Targeting
      • Max Planck Guest Laboratory
    • Scientific Cores Facilities
      • Scientific Cores Facilities
      • Microscopy Platform
      • Cytometry and Cell Sorting Platform
      • Bioinformatics Core Facility
  • Institutional
    • About us
    • Authorities and Staff
    • Scientific Advisory Board
    • Board of Trustees
    • Facts & Figures
    • Institutional Relations and Society
  • Communication
    • News
    • Events
    • Press and Multimedia
    • Max Planck Research Magazine
  • Career
  • Contact

Daily Archives: 18 July, 2024

You are here:
  1. Home
  2. 2024
  3. July
  4. 18

Molecular mechanism that promotes resistance to cancer therapies has been revealed

NewsBy IBioBA18 July, 2024

The research group led by Dr. Eduardo Arzt published a paper in the journal Aging Cell in which they described a molecular mechanism that facilitates the persistence of tumor cells through a new pathway of cellular senescence, which could explain cellular resistance to cancer therapies. Senescence is a natural mechanism that occurs in response to…

©. IBioBA - MPSP. Instituto de Investigación en Biomedicina de Buenos Aires – CONICET – Instituto Partner de la Sociedad Max Planck de Alemania. Todos los derechos reservados.
Go to Top